We therefore propose that inhibition of canonical NF-κB by EBNA1 may not only contribute to the development of tissue hyperplasia but may also play a role in the pathogenesis of NPC via evasion of host immune responses during early EBV infection. Here, NFKB1 is linked to Epstein-Barr virus infection.